Toceranib (PHA 291639, SU 11654)
Important Notice: For research use only. We do not sell to patients.
Other Forms of Toceranib (PHA 291639, SU 11654)
Not your Region? View all Distributors
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Discription | Toceranib is a kinase inhibitor with both antitumor and antiangiogenic activity through inhibition of KIT, vascular endothelial growth factor receptor 2, and PDGFRβ. | ||
---|---|---|---|
Targets |
|
Catalog Num | A11581 |
---|---|
Formula | C22H25FN4O2 |
Molecular Weight | 396.46 |
CAS Number | 356068-94-5 |
SMILES | CC1=C(NC(=C1C(=O)NCCN2CCCC2)C)/C=C\3/C4=C(C=CC(=C4)F)NC3=O |
Synonyms | PHA 291639, SU 11654, PHA-291639, SU-11654, PHA291639, SU11654 |
Storage | Store lyophilized at -20ºC, keep desiccated. |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2